This report series examines quarterly trends in life sciences venture investment. Key findings for Q1 2024 include: • Life sciences VC deal value in Q1 totaled $7.8 billion, which represents a 22.1% increase in value from Q4 2023. A total of 349 life sciences deals were completed in Q1, a 20.7% decrease in deal count from Q4 2023. Q1 marked the slowest quarter for life sciences deal count since Q3 2017, but larger deal sizes buoyed cumulative value for the industry.
Please see full publication below for more information.
